BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 12, 2020
View Archived Issues
After injury, astrocytes can make interneurons
Read More
First patient enrolled in study of plasma-derived IgG product as treatment of COVID-19 in Israel
Read More
CAR T cells targeting CD30 safe and active in patients with Hodgkin's lymphoma
Read More
Efficient CNS microglia replacement strategy developed
Read More
First-in-human data for anti-miR-92a therapy, MRG-110
Read More
Smoking and COPD are associated with increased ACE2 in alveolar and bronchial epithelium
Read More
SCO-094 enters phase I testing in patients with type 2 diabetes mellitus
Read More
Pivotal CheckMate-649 and CheckMate-577 studies of Opdivo meet primary endpoints
Read More
Medshine Discovery discloses new TGFBR1 inhibitors
Read More
New NLRP3 inflammasome inhibitors discovered at NodThera
Read More
Camphor Pharmaceuticals synthesizes new prostanoid EP4 receptor antagonists
Read More
FDA issues complete response letter for Pedmark
Read More
Ascentage Pharma, University of Michigan patent Mcl-1 inhibitors
Read More
5'-nucleotidase inhibitors discovered by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical
Read More
Interim analysis data from ReDUX4 study of losmapimod in FSHD
Read More
Arcturus initiates dosing in phase I/II study of its COVID-19 vaccine candidate
Read More
Topline data presented from phase II study of leronlimab in mild to moderate COVID-19
Read More
Low-dose IL-2 shows potential for treating children with type 1 diabetes
Read More
New phase II trial explores use of M-5049 for COVID-19 pneumonia
Read More
FDA clears IND for phase I/II study of KAHR's DSP-107 in advanced solid tumors
Read More